Form 4: Health Catalyst CFO Sells Shares for Tax Obligations

Health Catalyst's Chief Financial Officer, Jason Alger, disposed of 20,619 common shares in a non-discretionary 'sell to cover' transaction related to RSU vesting.

Summary

• Jason Alger, Chief Financial Officer of Health Catalyst, Inc. (HCAT), reported a disposition of common stock.
• The transaction involved 20,619 shares of common stock.
• The shares were disposed of at a price of $2.9002 per share.
• This sale was a 'sell to cover' transaction, mandated by the issuer's equity incentive plans to satisfy tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs).
• The transaction was not a discretionary trade by the Reporting Person.
• Following this transaction, Jason Alger beneficially owns 246,414 shares of common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transaction is a non-discretionary 'sell to cover' for tax purposes, a routine event for RSU vesting, and not indicative of management's discretionary view on the stock.

Negatives

• The Chief Financial Officer's direct beneficial ownership of common stock decreased by 20,619 shares.

Future Outlook

This filing does not contain any forward-looking statements or guidance.

Industry Context

This routine insider transaction for tax purposes does not provide specific insights into broader industry trends or competitive landscape.

Stakeholder Impact

• Shareholders: The transaction represents a minor reduction in direct insider ownership, but it is a routine, non-discretionary event for tax purposes and typically does not signal a change in management's confidence or company fundamentals.

Key Dates

Keywords

Health Catalyst, HCAT, Form 4, Insider Trading, CFO, Stock Sale, Restricted Stock Units, RSU Vesting, Tax Withholding